The impact of body weight on rivaroxaban pharmacokinetics

ESSENTIALS: The optimal dosing strategy of rivaroxaban for patients at the extremes of body weight is not known. A pharmacokinetic study was conducted based in real‐world patients in a London teaching hospital. In the cohort of patients studied, weight on its own did not impact significantly on riva...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Res Pract Thromb Haemost
Hlavní autoři: Barsam, Sarah J., Patel, Jignesh P., Roberts, Lara N., Kavarthapu, Venu, Patel, Raj K., Green, Bruce, Arya, Roopen
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
Original Articles: Thrombosis
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058267/
https://ncbi.nlm.nih.gov/pubmed/30046688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12039
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky